ANURAG BANSAL: Open Payments
NPI 1346580917 · PITTSFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,357 in 37 payments from 8 companies in 2025. Trend: 2023 $197 · 2024 $396 · 2025 $1,357
Food & beverage: $1,357
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $258 |
| ABBVIE INC. | 9 | $256 |
| Eisai Inc. | 2 | $250 |
| Novartis Pharmaceuticals Corporation | 16 | $213 |
| UCB, Inc. | 1 | $125 |
| PFIZER INC. | 1 | $125 |
| Alexion Pharmaceuticals, Inc. | 1 | $106 |
| Biogen, Inc. | 1 | $23 |
Products named: Leqembi, KISUNLA, KESIMPTA, UBRELVY, Zilbrysq, NURTEC ODT, QULIPTA, AMYVID.
Industry payments across MA — which companies pay providers there.
